Skip to product information
1 of 1

Suzanne Taylor

Remedicalizing Cannabis: Science, Industry, and Drug Policy

Remedicalizing Cannabis: Science, Industry, and Drug Policy

💎 Earn 137 Points (£1.37) on this item.

Important: Dispatches within 2 to 4 weeks
Regular price £27.44 GBP
Regular price £29.99 GBP Sale price £27.44 GBP
Sale Sold out
Taxes included. Shipping calculated at checkout.

YOU SAVE £2.55

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension

Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.

  • More about Remedicalizing Cannabis: Science, Industry, and Drug Policy


The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. Remedializing Cannabis considers the botanical product and its potential to yield medical applications, and investigates the process whereby boundaries shift between illicit drug and licit medicine. Suzanne Taylor traces the issues and interests involved in this process, demonstrating the important roles of changing scientific knowledge, expert advice, industry, clinical trials, and patient activism.

Format: Hardback
Publication date: 31 October 2022
Publisher: McGill-Queen's University Press


When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade, cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. High-profile cases of parents campaigning for access to cannabis oil for severe and rare forms of epilepsy in their children are the most recent in a long line of controversies over cannabis and cannabis-based medicines.

With mounting questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it is crucial to understand how we have arrived at this situation. While the historical literature has focused on cannabis as an illicit substance, Remedializing Cannabis considers the botanical product and its potential to yield medical applications. Investigating the remedialization of cannabis, Taylor explores the process whereby boundaries shift between illicit drug and licit medicine. Basing her arguments on archival material from expert committees, researchers, and activists and in-depth interviews with key players, Suzanne Taylor traces the issues and interests involved in this process, demonstrating the important roles of changing scientific knowledge, expert advice, industry, clinical trials, and patient activism.

Remedializing Cannabis investigates the evolving tensions that have brought us to the current situation and demonstrates the role of history in understanding today's debates about cannabis.


Dimension: 229 x 152 (mm)
ISBN-13: 9780228011408

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details